Cited by 287Liver Diseases and ImmunityLiver physiology and pathologyPediatric Hepatobiliary Diseases and Treatments

The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.

Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches

Open access

Hirschfield, Gideon M., Heathcote, E. Jenny, Gershwin, M. Eric·2010·Gastroenterology

DOI 10.1053/j.gastro.2010.09.004

Open this paper in CoChat — free account Open PDF

Abstract

Cholestatic liver disorders are caused by genetic defects, mechanical aberrations, toxins, or dysregulations in the immune system that damage the bile ducts and cause accumulation of bile and liver tissue damage. They have common clinical manifestations and pathogenic features that include the responses of cholangiocytes and hepatocytes to injury. We review the features of bile acid transport, tissue repair and regulation, apoptosis, vascular supply, immune regulation, and cholangiocytes that are associated with cholestatic liver disorders. We now have a greater understanding of the physiology of cholangiocytes at the cellular and molecular levels, as well as genetic factors, repair pathways, and autoimmunity mechanisms involved in the pathogenesis of disease. These discoveries will hopefully lead to new therapeutic approaches for patients with cholestatic liver disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2010.09.004

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin
Marzioni, M., Glaser, S. S., Francis, H., Marucci, L., Benedetti, A., Alvaro, D., Taffetani, S., Ueno, Y., Roskams, T., Phinizy, J. L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.002 · Cited by 177
Retracted
Immunol. Cell Biol.
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Primary Biliary Cirrhosis
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
Primary Biliary Cirrhosis
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Primary biliary cirrhosis
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citation
Primary biliary cirrhosis # †
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099

Flagged first, then by citations

Show all 187 references

1 of the 187 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–286 of 286

Exploration of Novel Metabolic Mechanisms Underlying Primary Biliary Cholangitis Using Hepatic Metabolomics, Lipidomics, and Proteomics Analysis.
Bao, J., Zhang, X., Ye, M., Yang, Y., Xu, L.-M., He, L.-L., Guo, J.-X., Yao, D.-K., Wang, S., Zhang, J., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00708 · Cited by 4
Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor
Xia, Y., Yan, S., Chang, Y., Yin, J., Li, H., & Yan, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1589388 · Cited by 5
Fecal Bile Acids in Canine Chronic Liver Disease: Results from 46 Dogs
Habermaass, V., Bartoli, F., Gori, E., Dini, R., Cogozzo, A., Puccinelli, C., Pierini, A., & Marchetti, V. (2024) · Animals · doi:10.3390/ani14213051 · Cited by 5
Liver allograft biopsies with histological cholestasis: a clinicopathological study of 254 cases from a single centre
Lo, R. C., Chan, K. K., Chok, K., & Ng, I. O. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204334 · Cited by 5
Correction of Toxic Liver Damage with a Multicomponent Herbal Extract in an Animal Experiment
Ferubko, E. V., Nikolaev Nikolaev, S. M., Dargaeva, D., & Rendyuk, T. D. (2020) · Pharmacognosy Journal · doi:10.5530/pj.2020.12.25 · Cited by 5
Antioxidant and hepatoprotective activities of Juniperus excelsa M. Bieb against bile duct ligation-induced cholestasis
Akbari, G., Abasi, M. R., Gharaghani, M., Nouripoor, S., Shakerinasab, N., Azizi, M., Salahi, M., Karimi, F., Eftekhari, M., Razmjoue, D., et al. (2024) · Research in Pharmaceutical Sciences · doi:10.4103/rps.rps_52_23 · Cited by 4
Sortilin in Biliary Epithelial Cells Promotes Ductular Reaction and Fibrosis during Cholestatic Injury
Hubel, E., Neumann, A., Fishman, S., Schaffer, O., Erez, N., Shrkihe, B. A., Shteingard, Y., Gross, T., Shibolet, O., Varol, C., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.01.023 · Cited by 4
Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury
García‐Sáez, J., Figueroa‐Fuentes, M., González‐Corralejo, C., Roncero, C., Lazcanoiturburu, N., Gutiérrez-Uzquiza, Á., Vaquero, J., Gonzalez‐Sanchez, E., Bhutia, K., Calero‐Pérez, S., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90645 · Cited by 4
Animal Models of Cholestasis
Fickert, P., Pollheimer, M. J., Österreicher, C. H., & Trauner, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00015-4 · Cited by 4
Quercetin mitigates liver injury in a rat model of liver cholestasis
Nassef, N. A., Abu-Shadi, E., Agaty, S. M. E., & Hamid, G. A. (2020) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2019.14512.1026 · Cited by 4
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile
Zheng, X., Dai, M., Xu, G.-M., Chang, L., Yang, J., & Liu, A. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4742 · Cited by 4
Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
Wang, R., Yuan, T., Sun, J., Yang, M., Chen, Y., Wang, L., Wang, Y., Chen, W., & Peng, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1064653 · Cited by 4
Protective Effects of Guava Pulp on Cholestatic Liver Injury
Peng, J. W., Yue, C., Qiu, K., Chen, J., Aller, M., Ko, K. S., & Yang, H. (2013) · ISRN Hepatology · doi:10.1155/2013/601071 · Cited by 4
Oxidative Stress in Liver Diseases
Fernández‐Iglesias, A., Hide, D., & Gracia‐Sancho, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805377-5.00009-6 · Cited by 4
Liver, Gallbladder, and Biliary Tract
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1781-5.00015-5 · Cited by 4
Natural killer T cells: Novel players in biliary disease?
Sebode, M., & Schramm, C. (2015) · Hepatology · doi:10.1002/hep.27862 · Cited by 4
Numb-exon3 and full length Numb equivalently alleviate cholestatic liver fibrosis by inhibiting ductular reaction
Xu, Y., Zong, M.-Y., Xu, W., Zhang, S.-H., Wang, D., Zheng, X.-R., Xing, F.-F., Zhan, J.-Y., Chen, J., Chen, G., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-23696-3 · Cited by 3
Cholestatic and autoimmune liver diseases, bile duct injury, oxidative stress, and therapeutic strategies
Stygar, D. M., Bogielski, B., Michalczyk, K., Skrzep-Poloczek, B., Suchocka, A., Nikiel, K., Kukla, K., Wasek, R., Staniszewski, J., Matyja, M., et al. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1788973 · Cited by 4
Colangitis biliar primaria: experiencia de cinco años en el Hospital Clínico de la Universidad de Chile
Ramírez, F., Urzua, A. M., Roblero, J. P., Cattaneo, M., Hurtado, C., & Poníachik, J. (2022) · Revista médica de Chile · doi:10.4067/s0034-98872022000700889 · Cited by 3
Cholestasis in Alcohol-Associated Liver Disease
Yan, S., & Yin, X. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.015 · Cited by 3
Emerging role of peroxisome proliferator-activated receptor agonists in the treatment of cholestatic liver disease
Bhushan, S. R., & Kowdley, K. V. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001109 · Cited by 3
Nodosin alleviates cholestatic liver injury by activation of SIRT1/FXR signaling pathway and inhibition of hepatic inflammation
Han, M., Cheng, Y., Wang, W., Ye, S., Kong, L., Zhang, Y., & Zhang, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117200 · Cited by 3
Protective effect of the ethyl acetate fraction of Qinghai-Tibet Plateau medicinal plant Chrysosplenium axillare Maxim. against ANIT-induced cholestatic liver injury in mice
Cai, Z., Li, W., Jiang, W. H., Zhu, J., Zhong, G., Wei, R., Mu, Z., & Ren, G. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100076 · Cited by 3
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 3
Vitexin: A Dietary Flavonoid with Potential Protective Effects Against Liver Diseases
Dai, S., Fu, K., Liu, Y., Yao, Y., Zhang, F., Wu, R., Guo, Y., Yao, C., & Li, Y. (2024) · Food Reviews International · doi:10.1080/87559129.2024.2347478 · Cited by 3
Network toxicology and molecular docking reveal the mechanistic basis of bisphenol A-mediated cholestatic liver injury
Tang, Y., She, L., Sun, Y., Zhu, Z., & Zhu, P. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102167 · Cited by 2
Microbiota in cholestatic diseases: crosstalk among bile composition, the biliary microbiome, and host immunity
Yang, Y., Ren, L., Zhang, Y., Wang, X., Shang, J., & Zhang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1884030 · Cited by 2
iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats
Wang, D., Yu, H., Li, Y., Xu, Z., Shi, S., Dou, D., Sun, L., Zheng, Z., Shi, X., Deng, X., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10446 · Cited by 2
miR-194 Up-Regulates Cholesterol 7 Alpha-Hydroxylase Expression via β-Catenin Signaling and Aggravates Cholestatic Liver Diseases
Chen, P., Hsu, C.-P., Wang, S.-Y., Wu, T.-Y., Lin, Y.-J., Chen, Y., & Hsu, S. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.007 · Cited by 2
Scoparone attenuates cholestatic liver injury through regulating hepatic bile acid metabolism, ameliorating periductal fibrosis and inhibiting inflammatory response
Hao, J., Shen, X., Lu, K., Xu, Y., Chen, Y., Liu, J., Shao, X., Zhu, C., Ding, Y., Xie, X., et al. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100292 · Cited by 2
PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling
Li, D., Ye, C., Liu, P., Sun, T., Qin, Y., & Wan, X. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152097 · Cited by 2
Multiparameter assessment of hepatobiliary excretion dysfunction in cholestasis via dynamical photoacoustic and NIR-II fluorescence imaging
Zhou, Q., Huang, G., Chen, J., Qin, A., Li, H., & Nie, L. (2025) · Photonics Research · doi:10.1364/prj.564269 · Cited by 2
A novel mechanism involving USP53-regulated BSEP trafficking underlies low-GGT intrahepatic cholestasis
Ding, J. P., She, H.-Y., Cheng, Y., Sun, H.-Y., Feng, J., Liu, T., Qiu, Y., Wei, B.-X., Zhang, J., Su, Y., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001501 · Cited by 2
Morphological changes in the liver of rats after administration of chlorpromazine, depending on the dose and duration of administration
Baylo, O. V., & Rykalo, N. A. (2023) · Reports of Morphology · doi:10.31393/morphology-journal-2023-29(1)-10 · Cited by 2
Soluble epoxide hydrolase inhibition: a novel therapeutic strategy in alcoholic liver disease.
Warner, J. B. (2020) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3481 · Cited by 2
Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
Rawashdeh, B., Couillard, A. B., Rawshdeh, A., Aziz, H., Esteban, J. P., & Selim, M. A. (2022) · Gene Expression · doi:10.14218/ge.2022.00016 · Cited by 1
Engineered Exosomes Carrying Super-Repressor IκB Reduced Biliary Atresia-Induced Liver Fibrosis in Minipig and Mouse Models
Kang, J., Park, C., Yun, H., Choi, C., & Seo, W. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020264 · Cited by 1
Effects of saponin on testes oxidative stress, apoptosis, and steroid hormone synthesis pathway in bile duct ligation model of obstructive cholestasis in male Wistar rats
Mavaddat, H., Ale‐Ebrahim, M., & Aghdam, D. S. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110020 · Cited by 1
Sex-Dependent Regulation of Liver Fibrosis in Primary Sclerosing Cholangitis: The Role of miR-125b, Androgen Receptors, TGF-β, and Apelin Signalling
Abramczyk, J., Milkiewicz, M., Łaba, A., Milkiewicz, P., Bañales, J. M., & Kempińska‐Podhorodecka, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167784 · Cited by 1
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes
Valestrand, L., Nordhus, K. S., Claudel, T., Øgaard, J., Frank, A. K., Amundsen-Isaksen, E., Fuchs, C. D., Berntsen, N. L., Chung, B. K., Jiang, X., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000862 · Cited by 1
Single-cell RNA sequencing and spatial transcriptomic analysis reveal a distinct population of G6PD+ cells with aberrant bile acid metabolism in hepatocellular carcinoma
Jiang, X., Quan, H., Yin, T., Yao, H., Li, Y., Peng, B., Yuan, X., Zeng, W., Chen, H., & Li, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739293 · Cited by 1
Some Findings on Apoptosis in Hepatocytes
Tsuji, M., & Oguchi, K. (2012) · InTech eBooks · doi:10.5772/51015 · Cited by 1
Correlation between alkaline phosphatase, g-glutamyl transpeptidase, and bilirubin with interleukin-1b level in dogs with obstructive jaundice
Setyawan, N., & Budipramana, V. S. (2015) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci004704201502 · Cited by 1
Experimental models of fibrosis
Косолапов, В. А., Litvinov, R., & Спасов, А. А. (2024) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2024-21-3-39-47 · Cited by 1
Partial Ligation of the Common Bile Duct Results in Reversible Cholestasis in Rats
Jiang, J., Li, D., Wei, J., Jiang, K., & Miao, Y. (2016) · International Surgery · doi:10.9738/intsurg-d-15-00164.1 · Cited by 1
EVALUATION OF ANTIOXIDANT ACTIVITY OF PLANT AGENTS
Ferubko, Y. V., Николаевич, З. В., Lapin, A. A., & Dargayeva, T. D. (2020) · chemistry of plant raw material · doi:10.14258/jcprm.2020047750 · Cited by 1
Jaundice in Pancreatic Cancer
Ceniceros, L., Prados, S., & Álvarez-Gallego, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_78 · Cited by 1
The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota
Kou, Y., Zheng, X., Meng, L., Liu, M., Xu, S., Jing, Q., Zhang, S., Wang, H., Han, J., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.773341 · Cited by 1
ЖЕЛЧЕГОННОЕ ДЕЙСТВИЕ ЭКСТРАКТА СУХОГО CARTHAMUS TINCTORIUS L.
Банзарова, Б. Г. У. И. Д., Николаев, С. М., РАН, И. О. И. Э. Б. С., Александрович, Ч. С., Банзарова, Б. Г. У. И. Д., Анатольевна, Р. О., Банзарова, Б. Г. У. И. Д., Хитрихеев, В. Е., & Банзарова, Б. Г. У. И. Д. (2021) · Вестник Бурятского государственного университета. Медицина и фармация · doi:10.18101/2306-1995-2021-1-3-8 · Cited by 1
Autoimmune Liver Diseases in Canterbury, New Zealand
Ngu, J. H. (2013) · Otago University Research Archive (University of Otago) · Cited by 1
ROLE OF BILE ACIDS AND FARNESOID X RECEPTOR IN HEPATIC AUTOPHAGY AND ITS IMPLICATIONS IN ETHANOL-INDUCED HEPATOTOXICITY
Manley, S. (2014) · KU ScholarWorks (The University of Kansas)
Clinical Variants of Primary Sclerosing Cholangitis: When Does Liver Biopsy Make the Diagnosis?
Floreani, A. (2011) · InTech eBooks · doi:10.5772/21257
Chronic Cholestatic Liver Disease and its Management in Adults and Children
Hirschfield, G. M., & Kamath, B. M. (2012) · doi:10.1002/9781118314968.ch20
Self-citation
The Diagnosis and Classification of Immune-Mediated Biliary Diseases
Hirschfield, G. M. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_9
Self-citation
Isolation and expansion of a unique stem cell population from human and mouse gallbladders
Manohar, R. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
940 LOSS OF KERATIN 19 PREDISPOSES TO THE DEVELOPMENT OF CHOLESTATIC LIVER DISEASE
Chen, Y., Güldiken, N., Omary, M. B., Haybäck, J., & Strnad, P. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60952-0
New approaches for cholestasis in hemoglobinopathies
Dhiman, P., Saxena, P., Bihari, C., Rastogi, A., & Sarin, S. K. (2015) · Blood Research · doi:10.5045/br.2015.50.2.118
A case of primary sclerosing cholangitis with unique clinical features for a 5-year follow up
Nakagawa, M., Asahina, Y., Murakawa, M., Nagata, H., Kaneko, S., Otani, S., Kawai‐Kitahata, F., Nitta, S., Nishimura‐Sakurai, Y., Itsui, Y., et al. (2016) · Kanzo · doi:10.2957/kanzo.57.382
The expression studies of Bcl-xl gene subsequent effect of cholestasis and treatment by curcumin in hippocampus of male rats
Baghbaderani, S., Nasehi, M., & Hashemi, M. (2018) · فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران · doi:10.29252/iau.28.1.37
A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata)
Ryu, B., KyungYeon, E., Jang, J.-J., Kim, C., Lee, J. M., Oh, H., Kim, U., Kim, J., Lee, H., Jung, Y.-M., et al. (2018) · Journal of Medical Primatology · doi:10.1111/jmp.12347
Acute Exposure to TCDD Increases Liver Disease Progression in Mice With Carbon Tetrachloride-Induced Liver Injury
Cholico, G. N. (2019) · doi:10.18122/td/1632/boisestate · Cited by 1
Non-tumoral Pathology of the Intrahepatic Biliary Tract
Kovač, J. D. (2020) · Medical radiology · doi:10.1007/978-3-030-38983-3_18
Herbal Medicines Intended for Correction of Digestive System Diseases
Ферубко, Е. В., Rendyuk, T. D., Dargaeva, T. D., & Николаев, С. М. (2022) · Pharmacognosy Journal · doi:10.5530/pj.2022.14.17
Hepatology Summary
Greenberger, N. J. (2014) · doi:10.1093/med/9780199358274.003.0076
Soluble epoxide hydrolase inhibition: a novel therapeutic strategy for alcohol-associated liver disease.
Warner, J. B. (2023) · doi:10.18297/etd/4066
Forward genetics combined with unsupervised classifications identified zebrafish mutants affecting biliary system formation
Singh, D. J., Tuscano, K. M., Ortega, A. L., Dimri, M., Tae, K., Lee, W., Muslim, M. A., Paz, I. R., Liu, J. L., Pierce, L. X., et al. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.05.005
Gallstone Formation Post-Excessive Weight Loss: Mechanisms and Preventive Strategies
Silva, L. M. A., de Oliveira, A. B. L., Ferreira, L. M., Maia, D. K. D. C., Catharin, O. D. C., Lisboa, G. B., Fernandes, J. G. F., Pincelli, J. V., Lima, E. W. N. C., Gouveia, V. J. D. A. E., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594782419084
Animal models of biliary/cholestatic disease
Kaur, S., & Tripathi, D. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99478-1.00008-0
Synergistic action of cilnidipine and bexarotene in mitigating cholestatic liver damage: role of FXR signaling cascade
Mohammed, T. A., & Zalzala, M. H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04061-7
Supplementing HIV-ART with cannabinoids increases serotonin, BHB, and Ahr signaling while reducing secondary bile acids and acylcholines
Premadasa, L. S., Romero, L., & Mohan, M. (2025) · Science Advances · doi:10.1126/sciadv.adw4021
Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response
González‐Corralejo, C., García‐Sáez, J., Figueroa‐Fuentes, M., Addante, A., Roncero, C., Lazcanoiturburu, N., Pacheco, B., Sanz, J., Gato, C., Fernández‐Calderón, E., et al. (2025) · FEBS Journal · doi:10.1111/febs.70315
Additional file 1 of Engineered FGF19ΔKLB protects against intrahepatic cholestatic liver injury in ANIT-induced and Mdr2-/- mice model
Shi, L., Zhao, T., Huang, L., Pan, X., Wu, T., Feng, X., Chen, T., Wu, J., & Niu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26622472
Additional file 1 of TNF-α/IL-1β-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2/PGE2 pathway
Luan, X., Chen, P., Li, Y., Yuan, X., Miao, L., Zhang, P., Cao, Q., Song, X., & Di, G. (2023) · Figshare · doi:10.6084/m9.figshare.22688598
Preclinical mouse models for studying cholangiocarcinoma
Yang, S., Bao, C., Li, Y., Ou, Y., Jiang, Y., Xu, W., Zheng, D., Li, N., Yang, M., Wang, F., et al. (2026) · Liver Research · doi:10.1016/j.livres.2026.01.002
Induction d’une cholestase par la chlorpromazine dans les cellules hépatiques humaines HepaRG : Etude des mécanismes impliqués et de l’influence d’un stress inflammatoire.
Azzi, P. B.-E. (2014) · theses.fr (ABES) · doi:10.70675/d0af19f3z4cc8z45eazb1c0z81789ba3e65c
Design, synthesis and biological evaluation of novel anti-inflammatory agents
Sava, A. (2021) · theses.fr (ABES) · doi:10.70675/9d9e1f52ze82fz4140zbdefz367ec5062461
Tumor necrosis factor receptor superfamily member 13B mutation-associated chronic cholangitis with cirrhosis: A case report and review of literature
Zhou, Y., Cheng, Q., Liang, M.-X., Li, S.-Q., Su, Y.-Z., Cai, Y.-M., Pan, Z.-Q., Xie, Y.-X., Chen, Y., & He, Y.-H. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i4.117993
Liver-nervous system axis: pathways, dysregulation, and translational perspectives
Hao, D., Hu, Y., Luo, W., Li, S., Yan, Y., & Zhou, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03875-3
Intestinal Sirtuin 1 Controls Liver Regeneration via Regulating the Intestinal Farnesoid X Receptor/Fibroblast Growth Factor 15 Axis in Mice
Seaman, S., Ruiz, P., Nirello, V. D., Martin-Castilla, L., Elizalde-Garcia, P., Vega-Zuza, A., Vegas-Petrina, L., Lumbreras-Perales, C., Philo, M., Moreno‐Gonzalez, M., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101813
Features of the course of primary biliary cholangitis in women at different age periods: Literature review
Bulatova, I. A., Shevlyukova, T. P., Щекотова, А. П., Shchekotova, I. V., & Попова, Е. В. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-201
Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies
Hayes, C. M., Cross, D. R., Achour, B., & Ghonem, N. S. (2026) · Cells · doi:10.3390/cells15161442
The instructive scar – the dynamic role of extracellular matrix in biliary pathophysiology
Waddell, S. H., Brennan, E., & Boulter, L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052835
Stevioside promotes hepatocyte proliferation via YAP signaling in cholestatic disease
Jiang, W., Fang, X.-Y., Sun, Y.-M., Xu, M.-Y., Han, X., Yan, S.-J., Liu, X., Liu, Y.-Y., Zeng, X., Lai, W., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01914-6
Immune cell remodelling and the peribiliary immune niche in primary biliary cholangitis: from initiation to chronicity
Xiong, J., Zhang, Z., Zhang, Z., Yuan, M., Zhu, K., Wang, F., & Shi, L. (2026) · eGastroenterology · doi:10.1136/egastro-2026-100526
Decoding the Cellular Response to Methylthioadenosine Uncovers Novel Targets for Chronic Liver Disease
Blázquez‐García, I., Guerrero, L., Tai, M. D. S., Cerqueira, A., Cuervo, A., Paradela, A., & Corrales, F. J. (2026) · Cells · doi:10.3390/cells15191720
WTAP resists cholestatic liver injury by m 6 A-IGF2BP1-dependent regulation of the nuclear receptor FXR
Ju, G., Wu, T., Wu, Y., Zhou, X., Yang, Y., Meng, X., Jin, C., Chen, H., 孙科, Yu, M., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337845

Authors: Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E.
Affiliations: University of Toronto (CA)
University of California, Davis (US)
Corresponding author: Gershwin, M. Eric
ORCID: Hirschfield, Gideon M.
Gershwin, M. Eric
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2010-11
Volume: 139
Issue: 5
Pages: 1481-1496
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2010.09.004
OpenAlex: W2079853302
Cited by: 287
References: 187
Citations by year: 2026: 15 · 2025: 20 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 19 · 2020: 21 · 2019: 16 · 2018: 19 · 2017: 17 · 2016: 14 · 2015: 14 · 2014: 21 · 2013: 16 · 2012: 21
FWCI: 2.32
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Canadian Institutes of Health Research (MOP74621)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 39588)
Topics: Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords: cholestatic liver disease, pathogenesis, cholangiocytes, bile acid transport, cholestasis, bile duct injury, hepatocyte injury, tissue repair, apoptosis, blood supply, immune regulation, autoimmunity, genetic disorders, treatment options
MeSH terms: Animals, Bile, Cholagogues and Choleretics, Cholestasis, Humans, Immunity, Cellular, Immunosuppressive Agents, Liver Cirrhosis, Biliary, Prognosis, Risk Factors, Ursodeoxycholic Acid, Cytokines, Apoptosis, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks